Sound waves plus drug show promise against deadly brain tumor in small pilot
NCT ID NCT04446416
First seen Apr 23, 2026 · Last updated Apr 23, 2026
Summary
This small pilot study tested whether adding a focused ultrasound device (NaviFUS) to standard chemotherapy (bevacizumab) is safe and helps control tumor growth in 6 adults with recurrent glioblastoma, an aggressive brain cancer. Participants had already received standard treatments. The study measured side effects, tumor shrinkage, and how long the disease stayed under control. Results are limited due to the very small number of participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Linkou Chang Gung Memorial Hospital
Taoyuan, 33305, Taiwan
Conditions
Explore the condition pages connected to this study.